Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

2019
New York

The meeting place of peers and industry leaders in the NY/NJ biopharm community

This invitation-only, off-the-record forum brings together senior-level life sciences executives to network and share insights into the industry's challenges and opportunities.

Brochure Download

Learn more about the 2018 event highlights.

2018 Event Highlights

Keynote with Alex Denner on Board Governance

Check out the keynote discussion on Board Governance which featured Alex Denner, Hedge Fund Operator and CIO of Sarissa Capital Management, arguably one of the biggest influencers in biopharma today.

War Stories with Jeremy Levin

Industry veteran, Jeremy Levin, CEO, Ovid Therapeutics, candidly shared his war stories on-site.

The First US Gene Therapy Approval!

The 2018 program covered the journey of Spark Therapeutics with its first US Gene Therapy approval in December 2017, what’s happened in the past 12 months, and what their CEO Jeff Marazzo anticipates in the year ahead.

Capital Investment, Partnerships, Market Outlooks

Keep your finger on the pulse of what is happening nationally in capital investment, partnerships, market outlooks and the state of the industry, plus how that plays out at the local level.

New York Investment Opportunities & Funding Initiatives

Senior-level peers sat in on a VC panel to hear what makes New York a unique opportunity for investment and biotech building.

Get an update on how funding initiatives are overcoming the challenges in real estate and talent for biotech development in New York.

A Focus on Innovative LS Tech Companies

Experience a spotlight session on Innovative Tech Life Science companies and feed your visionary ideas.


The Ultimate Pharma R&D Annual Review 2018


Access the ultimate report to tune into expert insights and score illuminating data on the trends that affected pharmaceutical R&D. 

This is a trusted and highly-anticipated review of trends in drug development.

“It reflects what's really happening in the industry today and will probably confirm and confound some of your own beliefs on what's hot and what's not.”Author, Ian Lloyd, Senior Director of Pharma project and Data Integration